Functional activity of immune cells in female MS-patients

Annals of Anatomy

Volumn 180, Issue 4, 1998, Pages 321-325

  Peters, C ^a   Lotzerich H ^a   Raabe Oekter, A ^a   Mucha, C ^a   Michna, H ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Activation marker; Burst activity; Lymphocyte subpopulations; Multiple sclerosis; Natural killer cytotoxicity; Phagocytic activity

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DISEASE DURATION; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MONOCYTE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PHAGOCYTOSIS;

EID: 0031844996     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-9602(98)80035-6     Document Type: Article

References (29)

1. Antel JP, Peeples DM, Reder AT, Arnason BGW (1984) Analysis of T-regulator cell surface markers and functional properties in multiple sclerosis. J Neuroimmunol 6: 93-103
2. Benczur M, Gy Petrányi G, Pálffy M, Gy Varga M, Téles B, Katsy B, Foldes T, Hollán SR (1980) Dysfunction of natural killer cells in multiple sclerosis - a possible pathogenetic factor. Clin Exp Immunol 39: 657-662
3. Calopa M, Bas J, Mestre M, Arbizu T, Peres P, Buendia E (1995) T cell subsets in multiple sclerosis: a serial study. Acta Neurol Scand 92: 361-368
4. Chofflon M, Weiner HL, Morimoto CH, Hafler DA (1988) Loss of functional suppression is linked to decrease in circulating suppressor inducer (CD4+2H4+) T cells in multiple sclerosis. Ann Neurol 24: 185-191
5. Chofflon M, Weiner HL, Morimoto GH, Hafler DA (1989) Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 25: 494-499
6. Compston DAS, Kellar Wood H, Robertson N, Sawcer S, Wood NW (1995) Genes and susceptibility to multiple sclerosis. Acta Neurol Scand 161: S43-S51
7. Constantinescu CS, Kamoun M, Dotti M, Farber RE, Galetta SL, Rostami A (1995) A longitudinal study of T-cell activation marker CD26 in chronic progressive multiple sclerosis. J Neurol Sci 130: 178-182
8. De Keyser J (1988) Autoimmunity in multiple sclerosis. Neurology 38: 371-374
9. Fredrikson S, Ernerudh J, Olsson T, Forsber GP, Link H (1989) Mononuclear cell types in cerebrospinal fluid and blood of patients with multiple sclerosis. Arch Neurol 46: 372-375
10. Gallo P, Chiusole M, Sanzari M, Sivieri S, Piccinno MG, Argentiero V, Rizzotti P, Tavolato B (1994) Effect of high-dose steroid therapy on T-cell subpopulations. Acta Neurol Scand 89: 95-101
11. Gallo P, Piccinno MG, Tavolato B, Siden A (1991) A longitudinal study on IL-2, sIL-2R, IL-4 and IFNγ in multiple sclerosis CSF and serum. J Neurol Sci 101: 227-232
12. Hafler DA, Weiner HL (1987) T cells in multiple sclerosis and inflammatory central nervous system diseases. Immunol Rev 100: 307-332
13. Hamann KP, Hopf HV (1986) Monocytes constitute the only peripheral blood cell population showing an increased burst activity in multiple sclerosis patients. Int Archs Allergy Immunol 81: 230-234
14. Hauser SL, Ault KA, Levin MJ, Garovoy MR, Weiner HL (1981) Natural killer cell activity in multiple sclerosis. J Immunol 127: 1114-1117
15. Hohlfeld R, Londai M, Massacesi L, Salvetti M (1995) T-cell autoimmunity in multiple sclerosis. Immunol Today 16: 259-261
16. Hommes OR, Brinkmann CJJ (1984) T-cell subsets in spinal fluid of multiple sclerosis patients. J Neuroimmunol 6: 123-130
17. Hughes PJ, Compston DAS (1988) Peripheral blood lymphocyte phenotype and function in multiple sclerosis. J Neurol Neurosurg Psychiatry 51: 1187-1192
18. Kellar-Wood HF, Wood NW, Holmans P, Clayton D, Robertson N, Compston DAS (1995) Multiple sclerosis and the HLA-D region: linkage and association studies. J Neuroimmunol 58: 183-190
19. Kurtzke JF (1995) MS epidemiology world wide. One view of current status. Acta Neurol Scand 161: S23-S33
20. Macor S, Porrini AM, Giampietro A, Malatesta G, Gambi D (1991) Multiple sclerosis: an immune system activation disease. Acta Neurol (Napoli) 13: 590-596
21. McFarlin DE, McFarland HF (1982) Multiple sclerosis. N Engl J Med 307: 1183-1188
22. Mix E, Jenssen HL, Lehmitz R, Buddenhagen F, Hitsche B, Richter M (1988) Einfluß der Ultraviolettbestrahlung des Blutes (UVB) auf Zellvolumen, Zelladhärenz und Phagozytose bei Normalprobanden und Patienten mit Multipler Sklerose (MS). Folia Haematol 115: 669-687
23. Neighbour PA, Miller AE, Bloom BR (1981) Interferon responses of leucocytes in multiple sclerosis. Neurology 31: 561-566
24. Raine CS (1994) The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 36: S61-S72
25. Rauch HC, Montgomery JN, Kaplan J (1985) Natural killer cell activity in multiple sclerosis and myasthenia gravis. Immunol Invest 14: 427-434
26. Reddy MM, Goh KO (1976) B and T lymphocytes in man. III. B, T and "null" lymphocytes in multiple sclerosis. Neurology 26: 997-999
27. Rodeck U, Kuwert E, Keinecke HO (1983) Alters- und geschlechtsabhängige Veränderungen humaner T-Lymphozyten-Subpopulationen. Dt med Wschr 108: 1880-1883
28. Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JE, McDowell F, Nagler B, Sibley WA, Tourtellotte WW, Willmon TL (1965) Problems of experimental trials of therapy in multiple sclerosis report: report by the panel on the evaluation of experimental trials of the therapy in multiple sclerosis. Ann NY Acad Sci 122: 552-568
29. Tienari PJ (1994) Multiple sclerosis: multiple etiologies, multiple genes? Ann Med 26: 259-269